×
About 73 results

ALLMedicine™ Lung Cancer Guidelines Center

Research & Reviews  16 results

Impact of Delays in Lung Cancer Treatment on Survival.
https://doi.org/10.1016/j.chest.2021.08.051
Chest Zuniga PVS, Ost DE

Aug 24th, 2021 - Timely care is an important dimension of health care quality, but the impact of delays in care on lung cancer outcomes is unclear. Quantifying the impact of delays in cancer treatment on survival is necessary to inform resource allocation, quality...

National lung cancer screening guidelines may miss younger African American individuals at high risk
https://www.mdedge.com/chestphysician/article/230226/lung-cancer/national-lung-cancer-screening-guidelines-may-miss-younger
Andrew D. Bowser, MDedge News

Oct 19th, 2020 - National guidelines failed to classify many younger African American lung cancer patients as being eligible for lung cancer screening in a recent retrospective study, the lead author reported at the annual meeting of the American College of Chest.

Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiother...
https://doi.org/10.1016/j.clon.2020.09.001
Clinical Oncology (Royal College of Radiologists (Great B... Evison M, Barrett E et. al.

Sep 27th, 2020 - There is a paucity of evidence on which to produce recommendations on neither the clinical nor the imaging follow-up of lung cancer patients after curative-intent radiotherapy. In the 2019 National Institute for Health and Care Excellence lung can...

Use of Palliative Radiotherapy for Stage IV Lung Cancer Patients with Thoracic Symptoms in the Veterans Health Administration (VHA)
https://www.mdedge.com/fedprac/avaho/article/207576/lung-cancer/use-palliative-radiotherapy-stage-iv-lung-cancer-patients?channel=53
Dawson D, Malhotra S et. al.

Sep 5th, 2019 - Background: Palliative radiotherapy plays an important role in metastatic lung cancer (LC) treatment. Of VHA LC patients, 46% present with metastatic disease.

Clinical utility of plasma-based digital next-generation sequencing in patients with ad...
https://doi.org/10.1093/annonc/mdy512
Annals of Oncology : Official Journal of the European Soc... Zugazagoitia J, Ramos I et. al.

Dec 12th, 2018 - Approximately 30% of tumor biopsies from patients with advanced-stage lung adenocarcinomas yield insufficient tissue for successful molecular subtyping. We have analyzed the clinical utility of next-generation sequencing (NGS) of cell-free circula...

see more →

Guidelines  3 results

Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd e...
https://doi.org/10.1378/chest.12-2349
Chest Leone FT, Evers-Casey S et. al.

May 10th, 2013 - Continued tobacco use in the setting of lung cancer management is frequently confounding and always of critical importance. We summarized the published literature concerning the management of tobacco dependence in patients with lung cancer and off...

Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749714
Chest Gould MK, Donington J et. al.

May 10th, 2013 - The objective of this article is to update previous evidence-based recommendations for evaluation and management of individuals with solid pulmonary nodules and to generate new recommendations for those with nonsolid nodules. We updated prior lite...

Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung canc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694611
Chest Socinski MA, Evans T et. al.

May 10th, 2013 - Stage IV non-small cell lung cancer (NSCLC) is a treatable, but not curable, clinical entity in patients given the diagnosis at a time when their performance status (PS) remains good. A systematic literature review was performed to update the prev...

see more →

News  10 results

7 in 2011: A Short List of Drugs to Watch
https://www.onclive.com/view/7-in-2011-a-short-list-of-drugs-to-watch

Dec 5th, 2020 - From tiny biotech firms to giant pharmaceutical companies, the oncology drug development pipeline is pulsing with activity. There are nearly 900 potential new medicines and vaccines to treat cancer under study in the United States, according to th...

High-risk Blacks Missed by Lung Cancer Screening Guidelines
https://www.staging.medscape.com/viewarticle/939437

Oct 20th, 2020 - National guidelines failed to classify many younger African-American lung cancer patients as being eligible for lung cancer screening in a recent retrospective study, the lead author reported at the annual meeting of the American College of Chest ...

National lung cancer screening guidelines may miss younger African American individuals at high risk
https://www.mdedge.com/chestphysician/article/230226/lung-cancer/national-lung-cancer-screening-guidelines-may-miss-younger
Andrew D. Bowser, MDedge News

Oct 19th, 2020 - National guidelines failed to classify many younger African American lung cancer patients as being eligible for lung cancer screening in a recent retrospective study, the lead author reported at the annual meeting of the American College of Chest.

Use of Palliative Radiotherapy for Stage IV Lung Cancer Patients with Thoracic Symptoms in the Veterans Health Administration (VHA)
https://www.mdedge.com/fedprac/avaho/article/207576/lung-cancer/use-palliative-radiotherapy-stage-iv-lung-cancer-patients?channel=53
Dawson D, Malhotra S et. al.

Sep 5th, 2019 - Background: Palliative radiotherapy plays an important role in metastatic lung cancer (LC) treatment. Of VHA LC patients, 46% present with metastatic disease.

Real-world snapshot of lung nodule management raises concerns
https://www.mdedge.com/pulmonary-health-hub/article/78743/pulmonology/real-world-snapshot-lung-nodule-management-raises
Patrice Wendling

Nov 6th, 2013 - CHICAGO – One in three patients sent to surgery for a suspicious lung nodule by their community pulmonologist did not have cancer in a retrospective analysis of 385 patients. In addition, half of patients with benign disease underwent an invasive.

see more →